搜尋結果
2024年5月10日 · Novavax has signed a multi-billion dollar deal with French drugmaker Sanofi to co-commercialize Novavax's protein-based COVID-19 vaccine starting in 2025. Sanofi will pay Novavax an upfront...
2024年5月17日 · Novavax Inc 15.66 +3.33% 15.66 market open • as of 24 May, 13:08 EDT +0.51 ( +3.33%) Summary Financials Analysis Earnings Investors Options Company History Related 1D 5D 1M 3M YTD 1Y 3Y 5Y Max ...
2024年5月14日 · NVAX is rated "Buy" with a 12-month target price of $19.75, a 59.53% upside from the current price of $12.38. See more. Strong SellSell Hold Buy Strong Buy. Buy. Based on 6 analysts. 12-month ...
2024年5月8日 · NOVAVAX, INC. 15,50 +2,31% 15,50 à la clôture +0,35 ( +2,31%) après la clôture • en date du 24 mai, 19:13 EDT 15,48 -0,02 ( -0,13%) Résumé Finances Analyse Bénéfices Investisseurs ...